|
Volumn 26, Issue 7 I, 2006, Pages 939-1010
|
Key articles, guidelines, and consensus papers relative to the treatment of dyslipidemias - 2005
|
Author keywords
Cholesterol; Coronary heart disease; Dyslipidemia; Guidelines; Hypercholesterolemia; Hypertriglyceridemia
|
Indexed keywords
ANTILIPEMIC AGENT;
ANTIOXIDANT;
APOLIPOPROTEIN;
ATORVASTATIN;
BEZAFIBRATE;
C REACTIVE PROTEIN;
CHOLESTEROL;
CLOFIBRATE;
COLESTYRAMINE;
EZETIMIBE;
FENOFIBRATE;
FIBRIC ACID DERIVATIVE;
FLUINDOSTATIN;
GEMFIBROZIL;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
HOMOCYSTEINE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
INTERLEUKIN 6;
LIPID;
LIPOPROTEIN;
LIPOPROTEIN A;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
MEVINOLIN;
MONOCYTE CHEMOTACTIC PROTEIN 1;
NICOTINIC ACID;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
PRAVASTATIN;
SIMVASTATIN;
TRIACYLGLYCEROL;
UNINDEXED DRUG;
ANGIOGRAPHY;
ATHEROGENESIS;
ATHEROSCLEROSIS;
CLINICAL TRIAL;
CONSENSUS;
CORONARY ARTERY DISEASE;
DYSLIPIDEMIA;
HEART INFARCTION;
HEART MUSCLE ISCHEMIA;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPERTRIGLYCERIDEMIA;
ISCHEMIC HEART DISEASE;
LIPID BLOOD LEVEL;
LIPID METABOLISM;
LIPOPROTEIN METABOLISM;
LIVER FIBROSIS;
LIVER TOXICITY;
LOW FAT DIET;
METABOLIC SYNDROME X;
MORBIDITY;
MORTALITY;
MYOPATHY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PATIENT COMPLIANCE;
PERIPHERAL NEUROPATHY;
PRACTICE GUIDELINE;
PRIMARY PREVENTION;
REVIEW;
RHABDOMYOLYSIS;
RISK FACTOR;
SECONDARY PREVENTION;
TENDON DISEASE;
CONSENSUS;
DYSLIPIDEMIAS;
GUIDELINES;
GUIDELINES AS TOPIC;
HUMANS;
|
EID: 33745726708
PISSN: 02770008
EISSN: None
Source Type: Journal
DOI: 10.1592/phco.26.7.939 Document Type: Review |
Times cited : (9)
|
References (3)
|